Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Percutaneous mitral annuloplasty

Maniu CY Patel JB, Reuter DG, et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol 2004 44 1652-1661. [Pg.602]

FIGURE 7.4 Percutaneous mitral annuloplasty device (MONARC System Edwards Lifesciences, Inc., with permission.)... [Pg.128]

These reports of early clinical experience in humans have shown that the concept of percutaneous mitral annuloplasty may be feasible for many patients with ischemic or functional mitral regurgitation. However,... [Pg.130]

Webb JG, Harnek J, Munt BI, et al. Percutaneous transvenous mitral annuloplasty initial human experience with device implantation in the coronary sinus. Circulation 2006 113 851-5. [Pg.139]

Dubreuil O, Basmadjian A, Ducharme A, et al. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation first in human experience with a temporary implant. Catheter Cardiovasc Interv 2007 69 1053-61. [Pg.139]

Despitetheselimitations, CARILLON Mitral Contour System has recently received CE Mark approval. More clinical experience is clearly warranted to further assess the role of percutaneous annuloplasty via coronary sinus remodeling in the treatment of mitral regurgitation. [Pg.130]

See other pages where Percutaneous mitral annuloplasty is mentioned: [Pg.128]    [Pg.129]    [Pg.128]    [Pg.129]    [Pg.597]    [Pg.125]    [Pg.128]    [Pg.128]   
See also in sourсe #XX -- [ Pg.128 , Pg.129 ]



SEARCH



Percutaneous

Percutaneous mitral annuloplasty device

© 2024 chempedia.info